VIDAS® TSH 30400-01Recalls & reported problems
Biomerieux SA · VIDAS TSH assay is intended for the determination of human TSH concentration in human serum or plasma as an aid in the diagnosis of thyroid or pituitary disorders. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 03573026156886), received between Dec 17, 2020 and Dec 17, 2020 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Incorrect, Inadequate or Imprecise Result or Readings2
Patient problems
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 17, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX THAT THEY HAVE OBSERVED FALSELY LOW RESULTS FOR A PATIENT'S SAMPLE IN ASSOCIATION WITH THE VIDAS® TSH 60 TESTS (REF.# (B)(4), LOT 1007944800) COMPARED TO RESULTS OBTAINED BY AN EXTERNAL LABORATORY. THE CUSTOMER STATED THAT THEY HAD TESTED A PATIENT FOR TSH ON THEIR VIDAS, THE RESULTS WERE AS FOLLOWS: PATIENT 2: VIDAS RESULT = 0.29 (UNITS NOT REPORTED). REPEAT ANALYSIS WITH THE VIDAS TSH OBTAINED THE SAME RESULTS. THE SAMPLE WAS THEN SENT TO AN EXTERNAL LABORATORY FOR REFERENCE TESTING AS THE CUSTOMER INDICATED THAT THE VIDAS RESULTS DID NOT MATCH THE LAST TIME THE TSH WAS RAN FOR THE PATIENT. THE EXTERNAL LABORATORY RESULTS WERE AS FOLLOWS: PATIENT 2: LABCORP RESULT = 3.30 (UNITS NOT REPORTED). THE CUSTOMER WAS UNSURE WHICH TEST METHOD WAS USED BY THE EXTERNAL LABORATORY. THE CUSTOMER REPORTED THAT NO INCORRECT RESULTS WERE REPORTED TO THE TREATING PHYSICIAN, THERE WAS NO DELAY IN REPORTING RESULTS, AND THIS EVENT DID NOT LEAD TO ANY ADVERSE EVENT RELATED TO THE PATIENT'S STATE OF HEALTH. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 11032502 ↗MalfunctionDec 17, 2020Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
A CUSTOMER IN THE UNITED STATES NOTIFIED BIOMÉRIEUX THAT THEY HAVE OBSERVED FALSELY LOW RESULTS FOR A PATIENT'S SAMPLE IN ASSOCIATION WITH THE VIDAS® TSH 60 TESTS (REF.#: (B)(4), LOT #:1007944800) COMPARED TO RESULTS OBTAINED BY AN EXTERNAL LABORATORY. THE CUSTOMER STATED THAT THEY HAD TESTED A PATIENT TSH SAMPLE ON THEIR VIDAS, THE RESULTS WERE AS FOLLOWS: PATIENT 1: VIDAS RESULT = 0.08 (UNITS NOT REPORTED). REPEAT ANALYSIS WITH THE VIDAS TSH OBTAINED THE SAME RESULTS. THE SAMPLE WAS THEN SENT TO AN EXTERNAL LABORATORY FOR REFERENCE TESTING AS THE CUSTOMER INDICATED THAT THE VIDAS RESULTS DID NOT MATCH THE LAST TIME THE TSH WAS RAN FOR THE PATIENT. THE EXTERNAL LABORATORY RESULTS WERE AS FOLLOWS: PATIENT 1: LABCORP RESULT = 4.08 (UNITS NOT REPORTED). THE CUSTOMER WAS UNSURE, WHICH TEST METHOD WAS USED BY THE EXTERNAL LABORATORY. THE CUSTOMER REPORTED THAT NO INCORRECT RESULTS WERE REPORTED TO THE TREATING PHYSICIAN, THERE WAS NO DELAY IN REPORTING RESULTS, AND THIS EVENT DID NOT LEAD TO ANY ADVERSE EVENT RELATED TO THE PATIENT'S STATE OF HEALTH. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 11032295 ↗
Other Radioimmunoassay, Thyroid-Stimulating Hormone devices
- VITROS 1912997Ortho Clinical Diagnostics · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE201 reports
- Alinity 07P4830Abbott Ireland · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE2 recalls91 reports
- Elecsys TSH 08443432190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE116 reports
- ARCHITECT 7K62-30Abbott Ireland · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE58 reports
- Elecsys TSH Assay 11731459122Roche Diagnostics GmbH · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE55 reports
- Access TSH (3rd IS) C28643Beckman Coulter, Inc. · Radioimmunoassay, Thyroid-Stimulating Hormone1 recall0 reports
- Alinity 07P4820Abbott Ireland · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE44 reports
- ARCHITECT 7K62-35Abbott Ireland · RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE25 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page